Search

You searched for "on-call"

606 results found

Ophthalmic viscoelastic devices: Useful insights for a novice cataract surgeon

4 February 2025 | | EYE - Cataract
Ophthalmic viscoelastic devices (OVDs) are essential in many different stages of cataract surgery. This article discusses the categories of OVDs and their respective properties, and highlights their uses in different scenarios faced in cataract surgery. Ophthalmic viscoelastic devices are gel-like...

COECSA-RCOphth LINK Partnership: Knowledge sharing from the conference scene

5 August 2026 | | EYE - General
Nick Astbury caught up with President of the Ophthalmology Society of Uganda (OSU), Faith Nakubulwa, and Angela Birungi, Scientific Chair for OSU, to discuss their key learnings taken away from the RCOphth 2026. Nick Astbury (NA): One of the key...

Eyecare challenges in the Middle East: Priorities of a global ophthalmology task force

2 June 2025 | | EYE - General
Global ophthalmology is a rapidly evolving, multidisciplinary field that integrates clinical practice, research, and policy at national and international levels. One of its main objectives is to improve eyecare equity worldwide by preventing avoidable vision impairment. Since the launch of...

Primary eye health care in low- and middle-income countries

2 February 2024 | | EYE - Cataract, EYE - Refractive, EYE - Paediatrics, EYE - Strabismus
The need for eyecare services in low- and middle-income countries Recent global estimates (2020) suggest that there is more than a three-fold difference in the prevalence of all categories of visual loss (presenting visual acuity <6/12 in the better eye)...

Issues with standard practice: Luer lock syringes in cataract surgery

4 December 2025 | | EYE - Cataract
For a few years, we have worked together with the practice variance surveys to tease out differences in the way we work and to discuss issues that arise. I hope that we have learnt some lessons and reflected on what...

Imaging within clinical research trials

5 August 2026 | | EYE - Imaging
Clinical research is essential to the future of healthcare and the wellbeing of patients, no matter what health condition they face. Many patients who choose to participate in clinical research studies in ophthalmology find optimism in discovering novel medicines to...

Cancer associated retinopathy

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...

#KnowYourDrops: breaking down barriers to poor compliance

1 June 2017 | | EYE - Glaucoma
Award-winning* #KnowYourDrops eye drop compliance campaign helps patients for World Glaucoma Week to achieve medicines optimisation in ophthalmology. The #KnowYourDrops campaign is fast becoming an internationally recognised model to help support healthcare professionals, with the provision of better tailored ophthalmic...

Refraction planning in cataract: avoid creating an unhappy patient

1 June 2017 | | EYE - Cataract, EYE - Refractive
“It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.” William Osler The focus of this paper is the prevention of an unhappy patient following cataract...

An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease

1 October 2016 | | EYE - Vitreo-Retinal
Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....

Management of diabetic macular oedema in vitrectomised eyes

1 August 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....

Optimising the ocular surface by managing meibomian gland dysfunction

1 February 2016 | | EYE - Cornea
Meibomian gland dysfunction (MGD) is ubiquitous. Ocular surface inflammation and irritation are prevalent in most ophthalmology clinics: corneal, cataract, glaucoma, oculoplastic, paediatric, vitreo-retinal, medical retina and refractive surgery. These patients also represent roughly one third of those attending for emergency...